The National Academies of Sciences, Engineering, and Medicine Board on Population Health and Public Health Practice will host a workshop Oct. 17-18 in Washington, D.C., on health system interventions to prevent firearm injury and death. The workshop will feature evidence and best practices and examine opportunities to improve efficacy by working with communities. Participants will include Jay Bhatt, D.O., AHA senior vice president and chief medical officer; David Grossman, M.D., and Gregory Simon, M.D., senior investigators for the Kaiser Permanente Washington Health Research Institute in Seattle; Bechara Choucair, M.D., chief community officer for Kaiser Permanente National Community Health; Elizabeth McGlynn, executive director of the Kaiser Permanente Center for Effectiveness and Safety Research; Lucas Neff, M.D., assistant professor of pediatric surgery at Wake Forest University Baptist Medical Center in Winston-Salem, N.C.; and Megan Bair Merritt, M.D., executive director of the Center for the Urban Child and Healthy Family; and Thea James, M.D., director of the Violence Intervention Advocacy Program at Boston Medical Center. For details and to register, click here.

Related News Articles

Headline
AHA podcast: Food as Medicine — How Cleveland Clinic Is Nourishing Community HealthVickie Johnson, executive vice president and chief community officer at…
Headline
As part of Community Health Improvement Week June 9-13, two experts from Corewell Health share how an impactful health care ecosystem model is supporting local…
Headline
With June 9-13 being Community Health Improvement Week, three experts from HonorHealth discuss how the health care network is addressing community needs beyond…
Blog
Even before the COVID pandemic, the mental health and wellness of our young people was failing. The pandemic exacerbated the crisis and made it difficult for…
Headline
A new AHA video highlights how Corewell Health is transforming youth behavioral health care access in rural Michigan through school-based clinics and…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…